Identification of Null Allelic Variant of CYP2C8 In A Korean Population

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The genotype profile of CYP2C8 was analyzed in a Korean population. Frequency in multi-ethnic population and in vivo functionality of novel null allelic CYP2C8 variant were evaluated.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Inje University
• Treatments: Rosiglitazone

Criteria

Inclusion Criteria:

• Healthy volunteer

Exclusion Criteria:

• Medical problems in taking probe drug